Renalytix PLC (RNLX)
0.4299
+0.02
(+3.64%)
USD |
NASDAQ |
Jun 03, 09:35
Renalytix Total Liabilities (Quarterly): 19.88M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 19.88M |
| December 31, 2023 | 19.21M |
| September 30, 2023 | 21.03M |
| June 30, 2023 | 23.66M |
| March 31, 2023 | 21.70M |
| December 31, 2022 | 21.78M |
| September 30, 2022 | 19.87M |
| June 30, 2022 | 19.46M |
| March 31, 2022 | 15.05M |
| December 31, 2021 | 8.557M |
| Date | Value |
|---|---|
| September 30, 2021 | 7.292M |
| June 30, 2021 | 7.476M |
| March 31, 2021 | 5.322M |
| December 31, 2020 | 4.118M |
| September 30, 2020 | 4.076M |
| June 30, 2020 | 5.336M |
| December 31, 2019 | 1.304M |
| June 30, 2019 | 1.149M |
| December 31, 2018 | 0.809M |
| December 31, 2018 | 0.809M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.149M
Minimum
Jun 2019
23.66M
Maximum
Jun 2023
12.57M
Average
11.80M
Median
Total Liabilities (Quarterly) Benchmarks
| TC BioPharm (Holdings) PLC | 7.807M |
| Ainos Inc | 7.076M |
| Aptorum Group Ltd | 5.257M |
| Adaptimmune Therapeutics PLC | 233.64M |
| Biodexa Pharmaceuticals Plc | 7.470M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.769M |
| Shareholders Equity (Quarterly) | -11.11M |
| Debt to Equity Ratio | -0.8407 |
| Current Ratio | 0.423 |
| Net Debt Paydown Yield | 1.02% |